Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LBH589 in Refractory Colorectal Cancer
NCT00690677Phase 2Completed
- Sponsor
- Swedish Health Services
- Start
- Jun 2008
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of panobinostat in colorectal cancer (CRC), sponsored by Swedish Health Services. Primary endpoint: Overall Survival at 18 months. Started Jun 2008; status: completed.
02
Drugs
panobinostat
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00690677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00690677.